Bicara Therapeutics Inc. (BCAX) stock
BCAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.75−0.27 (-2.69%)
Close on Nov 16, 2026Market cap $645.19MP/E –Yield –
Bicara Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Bicara Therapeutics's enterprise value was $197.00M on Nov 11, 2026, against $723.44M a year earlier. Over the last 2 years it ranged from -$215.28M to $1.41B, with a median of $427.06M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $197.00M | -68.7% |
| 2025 | Dec 31, 2025 | $628.96M | +47.3% |
| 2024 | Dec 31, 2024 | $427.06M | – |
See a number that looks wrong?